This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen acción DSM
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Recompensas
Análisis de riesgos
Competidores de DSM-Firmenich AG
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €114.05 |
| 52 Week High | €160.10 |
| 52 Week Low | €105.80 |
| Beta | 0.72 |
| 1 Month Change | -3.96% |
| 3 Month Change | -4.32% |
| 1 Year Change | -26.49% |
| 3 Year Change | -3.96% |
| 5 Year Change | 28.70% |
| Change since IPO | 1,649.00% |
Noticias y actualizaciones recientes
Recent updates
Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher
May 04
Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return
Mar 27Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 09Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching
Dec 06Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Oct 31Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching
Sep 19Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?
Aug 23Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Aug 08Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)
Jul 23Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 30Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 16Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's
Apr 02Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70
Mar 19Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly
Feb 19Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?
Nov 23We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt
Oct 01Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?
Aug 24Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet
Jun 29Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price
May 24Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 29Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?
Mar 15Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 01Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment
Feb 16Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares
Feb 04
Rentabilidad de los accionistas
| DSM | NL Chemicals | Mercado NL | |
|---|---|---|---|
| 7D | 0.3% | -3.0% | -0.9% |
| 1Y | -26.5% | -15.5% | 19.7% |
Rentabilidad vs. Industria: DSM underperformed the Dutch Chemicals industry which returned -20.7% over the past year.
Rentabilidad vs. Mercado: DSM underperformed the Dutch Market which returned 9.1% over the past year.
Volatilidad de los precios
| DSM volatility | |
|---|---|
| DSM Average Weekly Movement | 3.2% |
| Chemicals Industry Average Movement | 4.8% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in NL Market | 8.0% |
| 10% least volatile stocks in NL Market | 2.4% |
Precio estable de las acciones: DSM has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: DSM's weekly volatility (3%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1902 | 19,973 | Dimitri de Vreeze | www.dsm-firmenich.com |
Resumen de fundamentos de DSM-Firmenich AG
| Estadísticas fundamentales de DSM | |
|---|---|
| Capitalización bursátil | €763.73m |
| Beneficios(TTM) | €454.00m |
| Ingresos (TTM) | €8.39b |
1.7x
Ratio precio-beneficio (PE)0.1x
Ratio precio-ventas (PS)¿Está DSM sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DSM | |
|---|---|
| Ingresos | €8.39b |
| Coste de los ingresos | €5.70b |
| Beneficio bruto | €2.69b |
| Otros gastos | €2.24b |
| Beneficios | €454.00m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
Aug 02, 2023
| Beneficios por acción (BPA) | 67.80 |
| Margen bruto | 32.06% |
| Margen de beneficio neto | 5.41% |
| Ratio deuda/patrimonio | 26.6% |
¿Cómo se ha desempeñado DSM a largo plazo?
Ver rendimiento histórico y comparativa